Evidence map›Paper›PMID 18713944›Full record

ArticleBlood2008

Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines.

Chun I Yu, Michael Gallegos, Florentina Marches, Gerard Zurawski, Octavio Ramilo, Adolfo García-Sastre, Jacques Banchereau, A Karolina Palucka

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Blood, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02021422 (A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy Regimens in Metastatic Pancreatic Ductal Adenocarcinoma Patients), which is not on this map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02021422 phase1completednot on this mapstarted 2013, after this paper: background citation

A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy Regimens in Metastatic Pancreatic Ductal Adenocarcinoma Patients

TypeinterventionalSponsorBaylor Research InstituteRan2013 to 2021Enrolled13ConditionsPancreas CancerArmsanakinra, Oxaliplatin, Irinotecan, fluorouracil
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Animal Models of Hepatitis C Virus Infection.Cold Spring Harbor perspectives in medicine · 2020
    Review
  11. Review
  12. Article
  13. Article
  14. Humanized Mice as Unique Tools for Human-Specific Studies.Archivum immunologiae et therapiae experimentalis · 2018
    Review
  15. Review
  16. Article
  17. Article
  18. Application of Humanized Mice in Immunological Research.Methods in molecular biology (Clifton, N.J.) · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Chun I YuBaylor National Institute of Allergy and Infectious Diseases (NIAID) Cooperative Center for Translational Research on Human Immunology, Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
Michael Gallegos
Florentina Marches
Gerard Zurawski
Octavio Ramilo
Adolfo García-Sastre
Jacques Banchereau
A Karolina Palucka
National Institute of Allergy and Infectious Diseases · USIcahn School of Medicine at Mount Sinai · USThe University of Texas Southwestern Medical Center · US

Funding

Targeting Dendritic Cells for Enhanced Musocal ImmunityU19AI057234 · NIAID · BAYLOR RESEARCH INSTITUTE · PI PALUCKA, ANNA KAROLINA · 2003 to 2013
$49.2M
Technological Development ComponentU19AI062623 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI MORAN, THOMAS M · 2004 to 2009
$21.3M
SUBPOPULATIONS OF HUMAN DENDRITIC CELLSR01CA078846 · NCI · BAYLOR RESEARCH INSTITUTE · PI BANCHEREAU, JACQUES F · 1999 to 2008
$2.5M
Mice with Human Dendritic Cells to Test Vaccine PotencyR21AI056001 · NIAID · BAYLOR RESEARCH INSTITUTE · PI PALUCKA, ANNA KAROLINA · 2003 to 2004
$458k
NCI NIH HHS CA78846NCI NIH HHS R01 CA078846NIAID NIH HHS AI056001NIAID NIH HHS R21 AI056001NIAID NIH HHS U19 AI057234NIAID NIH HHS U19 AI062623
6 · The paper itself

Abstract

The development of novel human vaccines would be greatly facilitated by the development of in vivo models that permit preclinical analysis of human immune responses. Here, we show that nonobese diabetic severe combined immunodeficiency (NOD/SCID) beta(2) microglobulin(-/-) mice, engrafted with human CD34+ hematopoietic progenitors and further reconstituted with T cells, can mount specific immune responses against influenza virus vaccines. Live attenuated trivalent influenza virus vaccine induces expansion of CD8+ T cells specific to influenza matrix protein (FluM1) and nonstructural protein 1 in blood, spleen, and lungs. On ex vivo exposure to influenza antigens, antigen-specific CD8+ T cells produce IFN-gamma and express cell-surface CD107a. FluM1-specific CD8+ T cells can be also expanded in mice vaccinated with inactivated trivalent influenza virus vaccine. Expansion of antigen-specific CD8+ T cells is dependent on reconstitution of the human myeloid compartment. Thus, this humanized mouse model permits preclinical testing of vaccines designed to induce cellular immunity, including those against influenza virus. Furthermore, this work sets the stage for systematic analysis of the in vivo functions of human DCs. This, in turn, will allow a new approach to the rational design and preclinical testing of vaccines that cannot be tested in human volunteers.

Indexed as

Adoptive TransferAnimalsbeta 2-MicroglobulinCD8-Positive T-LymphocytesDendritic CellsHematopoietic Stem Cell TransplantationHumansImmunity, CellularInfluenza VaccinesLymphocyte TransfusionMiceMice, Inbred NODMice, KnockoutMice, SCIDTetanus ToxoidT-Lymphocytesbeta 2-MicroglobulinInfluenza VaccinesTetanus ToxoidViral Matrix ProteinsViral Nonstructural Proteins

Identifiers

PMID18713944
PMCPMC2572794
OpenAlexW1987499438

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.